EPISODE · Jul 8, 2026 · 7 MIN
Why don't we have a pan-tumor drug that targets BRCA mutations?
from PharmOncology · host Ming-Hei Tai
The challenges of targeting BRCA mutations in all cancersTumor lineage shapes BRCA-mediated phenotypes: https://pmc.ncbi.nlm.nih.gov/articles/PMC7048239/
Embed this episode
NOW PLAYING
Why don't we have a pan-tumor drug that targets BRCA mutations?
0:00
7:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of PharmOncology?
This episode is 7 minutes long.
When was this PharmOncology episode published?
This episode was published on July 8, 2026.
Can I download this PharmOncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!